|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| COST OF REVENUES | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES: | |||||
| Research and development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Change in earnout liability | |||||
| TOTAL OPERATING EXPENSES | |||||
| OPERATING LOSS | |||||
| Change in fair value of Forfeiture Shares | |||||
| Change in fair value of Forfeiture Shares | |||||
| Financial income, net | |||||
| LOSS BEFORE INCOME TAXES | |||||
| LOSS BEFORE INCOME TAXES | |||||
| INCOME TAXES | |||||
| LOSS AFTER INCOME TAXES | |||||
| Equity in earnings of investee | |||||
| NET LOSS | |||||
| Basic net loss per Ordinary Share (in Dollars per share) | |||||
| Diluted net loss per ordinary share (in Dollars per share) | |||||
| Weighted average number of shares and vested RSUs used in computing net loss per Ordinary Share (in Shares) | |||||
| Change in unrealized gains on cash flow hedges | |||||
| Change in unrealized gain (loss) on cash flow hedges | |||||
| TOTAL COMPREHENSIVE LOSS | |||||
Loading...